Genentech
E7901
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Genentech canonical | 32 |
| Genentech board of directors | 1 |
| Roche | 1 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
pharmaceutical company ⓘ subsidiary ⓘ |
| acquiredBy | Roche ⓘ |
| acquisitionDate | 2009 ⓘ |
| appliesMethod | genetic engineering ⓘ |
| collaboratedWith | Eli Lilly and Company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
biologic therapies
ⓘ
protein-based drugs ⓘ therapeutic antibodies ⓘ |
| focusesOn |
immunology
ⓘ
neuroscience ⓘ oncology ⓘ ophthalmology ⓘ |
| formerListedCompany | true ⓘ |
| foundedBy |
Herbert Boyer
ⓘ
Robert Swanson ⓘ |
| foundedIn | San Francisco Bay Area ⓘ |
| foundingDate | 1976 ⓘ |
| hasMajorTherapeuticArea |
autoimmune diseases
ⓘ
cancer ⓘ cardiovascular disease ⓘ |
| hasMotto | Doing now what patients need next ⓘ |
| hasResearchCenter | South San Francisco ⓘ |
| headquartersLocation |
South San Francisco
ⓘ
surface form:
South San Francisco, California
|
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
monoclonal antibody therapies
ⓘ
recombinant DNA–based medicines ⓘ |
| legalForm | corporation ⓘ |
| locatedInTheAdministrativeTerritorialEntity |
California, United States
ⓘ
surface form:
California
|
| notableFor | being one of the first companies to commercialize recombinant human insulin ⓘ |
| notableProduct |
Activase
ⓘ
Avastin ⓘ Herceptin ⓘ Lucentis ⓘ Perjeta ⓘ Rituxan ⓘ Tecentriq ⓘ Xolair ⓘ |
| numberOfEmployees | over 10000 ⓘ |
| operatesIn | biopharmaceutical research and development ⓘ |
| parentOrganization | Roche ⓘ |
| partOf |
Roche
ⓘ
surface form:
Roche Group
|
| stockExchange | New York Stock Exchange ⓘ |
| subsidiaryOf | Roche ⓘ |
| tickerSymbol | DNA ⓘ |
| website | https://www.gene.com ⓘ |
Referenced by (34)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Roche
this entity surface form:
Genentech board of directors
subject surface form:
Herbert Boyer